Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waldmann

Showing results (361-370 of 442) with videos related to

Pageof 45
Sort By:
Transplantation|August 1, 1989
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trialP J Friend, G Hale, H Waldmann, et al.
Cytotherapy|August 13, 2002
CAMPATH-1 antibodies in stem-cell transplantationG Hale, S Cobbold, N Novitzky, et al.
Transplantation Proceedings|February 1, 1987
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trialP J Friend, R Y Calne, G Hale, et al.
The New England Journal of Medicine|July 26, 1990
Monoclonal-antibody therapy in systemic vasculitisP W Mathieson, S P Cobbold, G Hale, et al.
Transplantation Proceedings|June 1, 1994
Cell- and tissue-specific expression of a human CD59 minigene in transgenic miceL E Diamond, E R Oldham, J L Platt, et al.
Lancet (London, England)|September 26, 1992
Humanised monoclonal antibody therapy for rheumatoid arthritisJ D Isaacs, R A Watts, B L Hazleman, et al.
Transplant Immunology|December 1, 1995
Human CD59 expressed in transgenic mouse hearts inhibits the activation of complementL E Diamond, K R McCurry, E R Oldham, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammationC M Lockwood, J D Elliott, L Brettman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
The British Journal of Surgery|November 1, 1993
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dogC J Watson, S P Cobbold, H S Davies, et al.
Pageof 45

Showing results (361-370 of 442) with videos related to

Sort By:
Pageof 45
Transplantation|August 1, 1989
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trialP J Friend, G Hale, H Waldmann, et al.
Cytotherapy|August 13, 2002
CAMPATH-1 antibodies in stem-cell transplantationG Hale, S Cobbold, N Novitzky, et al.
Transplantation Proceedings|February 1, 1987
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trialP J Friend, R Y Calne, G Hale, et al.
The New England Journal of Medicine|July 26, 1990
Monoclonal-antibody therapy in systemic vasculitisP W Mathieson, S P Cobbold, G Hale, et al.
Transplantation Proceedings|June 1, 1994
Cell- and tissue-specific expression of a human CD59 minigene in transgenic miceL E Diamond, E R Oldham, J L Platt, et al.
Lancet (London, England)|September 26, 1992
Humanised monoclonal antibody therapy for rheumatoid arthritisJ D Isaacs, R A Watts, B L Hazleman, et al.
Transplant Immunology|December 1, 1995
Human CD59 expressed in transgenic mouse hearts inhibits the activation of complementL E Diamond, K R McCurry, E R Oldham, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammationC M Lockwood, J D Elliott, L Brettman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
The British Journal of Surgery|November 1, 1993
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dogC J Watson, S P Cobbold, H S Davies, et al.
Pageof 45